In vivo, IL-17 deficiency enhanced glucose tolerance and insulin sensitivity in young mice, but simultaneously promoted adipocyte differentiation, leading to the increased accumulation of adipose tissue mass, the onset of obesity and the metabolic syndrome development. Here, INS is linked to metabolic syndrome.